Document ID: chunk:federal_register_of_legislation:F2017L00638:body:0:p2
Version: federal_register_of_legislation:F2017L00638
Segment Type: other
Provision Reference: 
Character Range: 2868–3963

or outcomes of ACM or its subcommittees, or ACV, about the evaluation of therapeutic goods under subsection 25(1) or subsection 9D(3) of the Act, including in relation to post-market pharmacovigilance requirements.
 8 Information in the minutes or outcomes of any other expert committee established by the Regulations about the suitability for inclusion in the Australian Register of Therapeutic Goods of therapeutic goods the subject of an application for approval.
 9 Information in any written decision made under subsection 25(3) of the Act in relation to the registration of therapeutic goods, including the reasons for the decision.
 10 Information in any written decision under section 60 of the Act on a review of a decision under subsection 25(3), subsection 9D(3), or subsection 25AA(1) or 25AA(4), of the Act, in relation to therapeutic goods.

Note
    1. All legislative instruments and compilations are registered on the Federal Register of Legislation kept under the Legislation  Act 2003. See http://www.legislation.gov.au

   Therapeutic Goods Information Specification 2017  3